InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001628280-25-040843 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-19 2025-08-15 TNDM Carpenter Rick CTO M - OptEx $0.00 +2,335 22.7K +11% $0
DM 2025-08-19 2025-08-15 TNDM Carpenter Rick CTO F - Tax $10.82 -1,187 21.9K -5% -$12.8K
DM 2025-08-19 2025-08-15 TNDM Carpenter Rick CTO M - OptEx $0.00 -2,335 4,311 -35% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-15 M A 898 $0.00 22,824 D — —
2 Common Common Stock 2025-08-15 F D 457 $10.82 22,367 D — — (F1) Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
3 Common Common Stock 2025-08-15 F D 730 $10.82 21,926 D — — (F1) Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
4 Common Common Stock 2025-08-15 M A 1,437 $0.00 22,656 D — —
5 Derivative Restricted Stock Unit 2025-08-15 M D 898 $0.00 6,281 D — · — to — 898 Common Stock (F5) Awarded on May 23, 2024 pursuant to the 2023 Plan. (F3) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F6) RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
6 Derivative Restricted Stock Unit 2025-08-15 M D 1,437 $0.00 4,311 D — · — to — 1,437 Common Stock (F2) Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). (F3) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F4) RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.